alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1367 Engrossed in House (EH)]

                In the House of Representatives, U. S.,

                                                         July 24, 2008.
    Resolved, That it shall be in order at any time on the legislative day of 
Thursday, July 24, 2008, for the Speaker to entertain motions that the House 
suspend the rules relating to the bill (H.R. 6578) to provide for the sale of 
light grade petroleum from the Strategic Petroleum Reserve and its replacement 
with heavy grade petroleum.
            Attest:

                                                                          Clerk.
```
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 16

- 20095 Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff

- Appellee

v.

JOSE BADILLO, JR., also known as Joe Badillo , also known as Jose A. Badillo

,

Defendant

- Appellant

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:15

- CR

- 493

- 1

Before HIGGINBOTHAM, JONES, and HIGGINSON, Circuit Judges.

PER CURIAM: *

The Federal Public Defender appointed to represent Jose Badillo, Jr.,

has moved for leave to withdraw and has filed a brief in accordance with
Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d
229 (5th Cir. 2011). Badillo h a s not filed a response. We have reviewed
counsel’s brief and the relevant portions of the record reflected therein. We

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED
October 18 , 2016

Lyle W. Cayce Clerk Case: 16-20095 Document: 00513721839 Page: 1 Date Filed: 10/18/2016No. 16

- 20095

2 concur with counsel’s assessment that the appeal presents no nonfrivolous
issue for appellate review . Accordingly, counsel’s motion for leave to withdraw
is GRANTED, counsel is excused from further responsibilities herein, and the

APPEAL IS DISMISSED. See 5 TH C IR

. R. 42.2. Case: 16-20095 Document: 00513721839 Page: 2 Date Filed: 10/18/2016
From: skellyoilco@hotmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:10:51 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Shawn Vouk

Saint Cloud, MN 56303
(R.D. 11476)

#### Browning Chemical Corp. *v.*United States

Entry No. 1093091.

(Decided January 24, 1968)

*Bharretts, Paley, Carter & Blauvelt*for the plaintiff.

*E&win L. Weisl, Jr.,*Assistant Attorney General, for the defendant.

Watson, Judge:

This appeal for reappraisement has been submitted for decision upon the following stipulation of counsel for the respective parties:

> IT IS HEREBY STIPULATED AND AGREED by and between counsel for the plaintiff and the Assistant Attorney General for the United States that the merchandise covered by the above enumerated appeal consists of titanium dioxide anatase exported from Japan during May, 1965, and that said merchandise is not on the list of products published in T.D. 54521 from which the application of the Customs Simplification Act of 1956 (P.L. 927, 84th Congress, 2nd Session) is withheld.

> IT IS FURTHER STIPULATED AND AGREED that the price at the time of exportation to the United States of the instant merchandise at which such or similar merchandise was freely sold, or in the absence of sales, offered for sale in the principal markets of the country of exportation, in the usual wholesale quantities and in the ordinary *767course of trade, for exportation to the United States, including the cost of all containers of whatever nature and all other expenses incidental to placing the merchandise in condition, packed ready for shipment to the United States was U.S. $385 per metric ton less the invoice ocean freight and insurance.

> IT IS FURTHER STIPULATED AND AGREED that the instant appeal is submitted for decision upon this stipulation.

On the agreed facts, I find and hold export value, as that value is defined in section 402(b) of the Tariff Act of 1930, as amended by the Customs Simplification Act of 1956, T.D. 54165, to be the proper basis for the determination of the value of the merchandise here in question and that such value was U.S. $385 per metric ton, less the invoice ocean freight and insurance.

Judgment will issue accordingly.
#### Dana L. Tracy, Appellant, v. William H. Baker, Respondent.

Motion to go to Court of Appeals denied.
Amendment No. 2 to Employment Agreement with G. Eric Davis



 Exhibit 10.6 
 AMENDMENT NO. 2 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of December 17, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and G. Eric Davis (“Employee”). 
  

	1.	This Amendment No. 2 is intended to amend and modify that certain Employment Agreement by and between the Company and Employee dated January 1, 2009 and amended on May
8, 2012 (the “Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in the Agreement.
Except as expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred forty percent (140%) of the Employee’s then current annual base salary which shall be payable in a lump sum within forty-five (45) days after separation of employment, conditioned
on Employee executing the Company’s standard form severance and release agreement within twenty (20) days of the Employee’s termination, and shall be subject to customary withholding and other applicable payroll processes. If Employee
fails to execute and deliver the Company’s standard form severance and release agreement within twenty (20) days after the Employee’s termination, Employee will have no right to any Termination Compensation under this Agreement.

  

	3.	This Amendment No. 2 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the date
first written above. 
  

									
	BIOMARIN PHARMACEUTICAL INC.	  		  	EMPLOYEE
					
	By:	 	 /s/ Jean-Jacques Bienaimé
	  		  	By:	 	 /s/ G. Eric Davis

	Name: Jean-Jacques Bienaimé	  		  		 	G. Eric Davis
	Its:      Chief Executive Officer
|        |
|--------|
|        |  |  |  |  |  |  |
|   | Title of Each Class of | Maximum Aggregate | Amount of |   |   |
|   | Securities Offered | Offering Price(1) | Registration Fee(2) |   |   |
|   |   |   |   |   |   |   |
|   | 1.850% PowerNotes® | Due June 15, 2021 | $1,875,000 | $188.81 |   |   |
|   |   |   |   |   |   |   |
|   | 2.250% PowerNotes® | Due June 15, 2023 | $2,241,000 | $225.67 |   |   |
|   |   |   |   |   |   |   |
|   | TOTAL |   |   | $414.48 |   |   |
|   |   |   |   |   |   |   |

|     |                                    |
|-----|------------------------------------|
| (1) | Excludes accrued interest, if any. |

|     |                                                                             |
|-----|-----------------------------------------------------------------------------|
| (2) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933. |

|        |
|--------|
|        |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   | CUSIP | Aggregate | Selling | Gross | Net |   | Coupon | Coupon | Coupon | Maturity | 1st Coupon | 1st |   | Survivor's |   | Product |   |   |
|   | Number | Principal | Price | Concession | Proceeds |   | Type | Rate | Frequency | Date | Date | Coupon |   | Option |   | Ranking |   |   |
|   |   | Amount |   |   |   |   |   |   |   |   |   | Amount |   |   |   |   |   |   |
|   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   | 14912HRZ5 | $1,875,000.00 | 100% | 1.250% | $1,851,562.50 |   | Fixed | 1.850% | Semi- | 06/15/2021 | 12/15/2016 | $9.87 |   | Yes |   | Senior Unsecured |   |   |
|   |   |   |   |   |   |   |   |   | Annual |   |   |   |   |   |   | Notes |   |   |
|   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

|        |
|--------|
|        |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   | CUSIP |   | Aggregate | Selling |   | Gross | Net | Coupon |   | Coupon | Coupon | Maturity | 1st Coupon |   | 1st |   | Survivor's |   | Product |   |   |
|   | Number |   | Principal | Price |   | Concession | Proceeds | Type |   | Rate | Frequency | Date | Date |   | Coupon |   | Option |   | Ranking |   |   |
|   |   |   | Amount |   |   |   |   |   |   |   |   |   |   |   | Amount |   |   |   |   |   |   |
|   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   | 14912HSA9 |   | $2,241,000.00 | 100% |   | 1.450% | $2,208,505.50 | Fixed |   | 2.250% | Semi- | 06/15/2023 | 12/15/2016 |   | $12.00 |   | Yes |   | Senior Unsecured |   |   |
|   |   |   |   |   |   |   |   |   |   |   | Annual |   |   |   |   |   |   |   | Notes |   |   |
|   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

----
EX-(4).(c)



 CONTRACT DATA PAGE 

 

			
	Contract Number:  [P9999999999] f1                	  	Contract Date:  [May 2, 2016] f1

  

					
	Owner:  [JOHN DOE] f1	  	    Date of Birth:  [March 1, 1976] f1	  	Age at
Issue:  
[35]f1


  

							
	2g
	 	[Owner:  [JANE DOE] f1	  	        Date of Birth:  [June 10, 1976] f1	  	Age at Issue:  [34] f1]
			
	Annuitant:  [JOHN DOE] f1	  	        Date of Birth:  [March 1, 1976] f1	  	Age at Issue:  [35] f1
				
	2g
	 	[Annuitant:  [JANE DOE]	  	        Date of Birth:  [June 10, 1976] f1	  	Age at Issue:  [34] f1]

 Beneficiary:  As named by You 

Initial Purchase Payment:  [$10,000.00]
f1

 Maximum Purchase Payment Without Our Approval:  [$1,000,000]f3 

Purchase Payment Age Limit:  [Prior to the 86th birthday]f4 

Minimum Subsequent Purchase Payment:  [$500]
f5

 Purchase Payments are subject to the limitations defined in this Contract. 

Fixed Account Options – Minimum Guarantee Rate:  [1.0%]
f6

 With 30 days advance notice, we may cease offering the Fixed Account Options, Fixed Account Guarantee Period Options and/or Dollar Cost
Averaging Fixed Account Options if market conditions are such that we are not able to credit the Minimum Guarantee Rate Shown on this page. 
 Fixed
Account Options:  [1 Year Fixed, 6 Month DCA Fixed, 1 Year DCA Fixed] f7

 Minimum Partial Withdrawal Amount:  [$1,000] f8 

Maximum Penalty-Free Withdrawal Percentage:  [10%]f9
 
 Minimum Systematic Withdrawal Amount:  [$100] f10 

Minimum Amount Remaining After a Partial Withdrawal: [$2,500]
f11

 
 Withdrawal Charge Schedule: 

 
 



 
 See Page [13] for Withdrawal Provisions.
f13

 Number of Full Years Elapsed Withdrawal Charge as a Between Purchase Payment Contribution Percentage of Withdrawn And Date of Withdrawal Purchase Payment

0 8% 
1 7% 
2 6% 
12 3 5% 
4 4% 
5+ 0% 

  

					
	US-803-P5 (12/15)	  	3	  	










 CONTRACT DATA PAGE (Cont’d.) 

 

 Minimum Transfer Amount:  [$100] f14 

Separate Account Charge (including guaranteed death benefit risk charge of [0.10%]): f15 

			
	Contract Years [1-5]: [1.55%]	 	  
 f15

	Contract Years [6 & Thereafter]: [1.30%]	 

 Annual Contract Maintenance Fee:  [$50]f16 

Transfer Fee:  [$25]
f17

 Earliest Annuity Date After the Contract Date:  13 months 

Latest Annuity Date:  [1st day of the month following Your 95th Birthday] f18 

Separate Account:  [FS VARIABLE SEPARATE ACCOUNT]
f19

  
  
 



 

  

					
	US-803-P5 (12/15)	  	4
#            

# CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (R)

With Maturities of 9 months or more from Date of Issue

Registration No.  333-109182

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO.  530                                                                   Trade Date:  01/24/05

(To Prospectus Supplement dated November 6, 2003 &

  Prospectus dated October 15,2003)                                                              Issue Date:   01/27/05

The Date of this Pricing SupplementJanuary 24, 2005

SUBJECT TO REDEMPTION OR REPAYMENT

 CUSIP                                                                                                                                   Date and terms of redemption or

     or       Stated                                                                   Interest                                       repayment (includingany

Common  Interest                      Price to  Discounts &        Payment     Survivors                  applicable regular or special

  Code      Rate (1)   Maturity  Public (2) Commissions       Frequency       Option  Yes/No     record dates)

14911QYB1  4.25%         07/15/12        100%                1.375%                Monthly                      YES         NO                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                       

Principal                                                                                 1st Payment             Day         

Amount                  Proceeds                  Dealer                           Date                   Count

$1,607,000.00         $1,584,903.75         ABN AMRO Inc.        02/15/05               30/360    

Original Issue DiscountNote:                                                                          Total Amount of OID:

____  Yes                X   No                                                                                  N/A

The interest rates on the PowerNotes (R) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (R) offered prior to the effective date of the change.  Prior to the date of this Pricing Supplement, $290.240 mm principal amount of the PowerNotes (R) were sold at interest rates then in effect.  Subsequent offerings of PowerNotes (R) will be made under the Prospectus Supplement and Prospectus dated October 15,2003.

Expressed as a percentage of aggregate principal amount.  Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
From: kathleenriordan39@comcast.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:05:35 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Kathleen Riordan

Milton, MA 02186
EXHIBIT 10-Y
------------
(C-XIV)

                        ALLONGE TO DEMAND NOTE

     Reference is made to that certain Demand Note, dated as of March 25,
1993 (the "Note"), made by Carlyle Real Estate Limited Partnership-XIV, an
Illinois limited partnership ("Carlyle XIV"), in favor of Carlyle Managers,
Inc., a Delaware corporation ("Investors"), in the original principal
amount of $1,200,000.

     In consideration for the return of capital made by Investors to
Carlyle XIV as of the date hereof in the amount of $800,000, the
undersigned hereby reduces the outstanding principal balance of the Note to
$400,000.  Such reduction shall not serve to reduce or cancel any accrued
and unpaid interest which may be outstanding on the Note.

     This Allonge shall be attached to and become a part of the Note.


Dated as of October 31, 1996.                  CARLYLE MANAGERS, INC.
                                               a Delaware corporation


                                               By:___________________
                                               Its:__________________

Acknowledged and Agreed:

CARLYLE REAL ESTATE LIMITED PARTNERSHIP-XIV
an Illinois limited partnership

By:  JMB REALTY CORPORATION,
     a Delaware corporation
     Corporate General Partner

     By:__________________
     Its:_________________
#### James Talcott, Respondent, v. Walter P. Hess, Appellant Lewis Mayer and others v. Walter P. Hess.

Judgments affirmed, with costs. Opinion by

Daniels, J.
EXHIBIT 31.2


                           CERTIFICATION

I, David R. Saracino, Treasurer and Chief Financial Officer,
certify, that:

     1.      I have reviewed this annual report on Form 10-K for
the period ended December 31, 2003, of First Keystone Corporation.

   2.      Based on my knowledge, the annual report does not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not
misleading with respect to the period covered by this annual
report.

   3.      Based on my knowledge, the financial statements, and
other financial information included in this quarterly report,
fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and
for, the periods presented in this annual report.

   4.      The registrant's other certifying officer and I are
responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14)
for the registrant and we have:

      a)   designed such disclosure controls and procedures to
   ensure that material information relating to the registrant,
   including its consolidated subsidiaries, is made known to us
   by others within those entities, particularly during the
   period in which this annual report is being prepared;

      b)   evaluated the effectiveness of the registrant's
   disclosure controls and procedures as of a date within 90
   days prior to the filing date of this annual report (the
   "Evaluation Date"); and

      c)   presented in this annual report our conclusions about
   the effectiveness of the disclosure controls and procedures
   based on our evaluation as of the Evaluation Date.

   5.      The registrant's other certifying officer and I have
disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent function):

      a)   all significant deficiencies in the design or
   operation of the internal controls which could adversely
   affect the registrant's ability to record, process, summarize
   and report financial data and have identified for the
   registrant's auditors any material weaknesses in internal
   controls; and

      b)   any fraud, whether or not material, that involves
   management or other employees who have a significant role in
   the registrant's internal controls.





                       /s/ David R. Saracino
                       David R. Saracino
                       Treasurer and Chief Financial Officer



Date:  March 12, 2004


                               27